We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNR
1876
DELISTED
Denbury Resources, Inc.
DNR
$6.67M ﹤0.01%
4,728,222
+459,974
+11% +$513K
SXC icon
1877
SunCoke Energy
SXC
$788M
$6.64M ﹤0.01%
1,065,374
+88,087
+9% +$489K
ATRI
1878
DELISTED
Atrion Corp
ATRI
$6.63M ﹤0.01%
8,820
+127
+1% +$95.8K
LGF.B
1879
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$6.62M ﹤0.01%
666,452
+58,402
+10% +$504K
CHK
1880
DELISTED
Chesapeake Energy Corporation
CHK
$6.61M ﹤0.01%
40,017
+7,468
+23% +$1.5M
EGRX
1881
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$6.6M ﹤0.01%
109,787
-3,921
-3% -$234K
NPKI
1882
NPK International
NPKI
$1.18B
$6.59M ﹤0.01%
1,051,129
+26,569
+3% +$173K
RGP icon
1883
Resources Connection
RGP
$145M
$6.58M ﹤0.01%
403,181
+67,875
+20% +$1.03M
TRTX
1884
TPG RE Finance Trust
TRTX
$616M
$6.58M ﹤0.01%
324,416
+5,388
+2% +$108K
PBI icon
1885
Pitney Bowes
PBI
$2.28B
$6.57M ﹤0.01%
1,629,297
+81,906
+5% +$375K
TFSL icon
1886
TFS Financial
TFSL
$4.93B
$6.54M ﹤0.01%
332,047
+6,720
+2% +$130K
PNTG icon
1887
Pennant Group
PNTG
$1.35B
$6.53M ﹤0.01%
+197,292
New +$4.52M
DNLI icon
1888
Denali Therapeutics
DNLI
$3.97B
$6.52M ﹤0.01%
374,478
+7,203
+2% +$120K
CUBI icon
1889
Customers Bancorp
CUBI
$2.82B
$6.52M ﹤0.01%
273,912
+4,587
+2% +$105K
USCR
1890
DELISTED
U S Concrete, Inc.
USCR
$6.52M ﹤0.01%
156,519
+21,150
+16% +$968K
ARR
1891
Armour Residential REIT
ARR
$2.37B
$6.51M ﹤0.01%
72,879
+2,821
+4% +$241K
INSP icon
1892
Inspire Medical Systems
INSP
$1.68B
$6.51M ﹤0.01%
87,720
+3,197
+4% +$205K
NX icon
1893
Quanex
NX
$981M
$6.48M ﹤0.01%
379,318
-3,949
-1% -$74.3K
BATRK icon
1894
Atlanta Braves Holdings Series B
BATRK
$3.41B
$6.47M ﹤0.01%
219,101
+7,462
+4% +$212K
TRHC
1895
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$6.46M ﹤0.01%
132,708
+4,752
+4% +$223K
HFWA icon
1896
Heritage Financial
HFWA
$1.23B
$6.4M ﹤0.01%
226,252
+856
+0.4% +$23.6K
MTW icon
1897
Manitowoc
MTW
$753M
$6.38M ﹤0.01%
364,231
+41,883
+13% +$611K
EBSB
1898
DELISTED
Meridian Bancorp, Inc.
EBSB
$6.37M ﹤0.01%
316,987
+6,713
+2% +$132K
BAND
1899
Bandwidth Inc
BAND
$1.74B
$6.36M ﹤0.01%
99,293
+4,608
+5% +$267K
BPYU
1900
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$6.36M ﹤0.01%
344,676
+95,571
+38% +$1.81M

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.